Why raw data archiving is critical in stability programs:

Stability testing results are only as credible as the raw data supporting them. Chromatograms, instrument readouts, and raw calculation sheets form the foundational evidence for any reported result. Without properly archived original data, final results lose credibility—especially during audits or regulatory reviews. Archiving also supports reanalysis, investigations, and retrospective reviews.

Risks of incomplete or inaccessible raw data:

If chromatograms or printouts are missing or stored separately from the stability file, it creates gaps in traceability. Regulatory authorities may view this as a breach of data integrity. Inadequate documentation can lead to audit observations, product rejections, or forced study repetition. Archiving raw data alongside final reports reinforces transparency and data continuity.

Regulatory and Technical Context:

ICH and GMP expectations for data retention:

ICH Q1A(R2), 21 CFR Part 211, EU Annex 11, and WHO TRS 1010 require that all original laboratory data—including chromatograms and instrument outputs—be retained, traceable, and readily available for review. These records must follow ALCOA+ principles: Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available. Stability files must include this evidence in printed or validated electronic format.

Audit and submission considerations:

Regulators routinely request raw chromatograms and data logs for verification. If a reported result (e.g., assay or impurity) cannot be traced back to its chromatogram or audit trail, the data may be deemed invalid. Regulatory submissions referencing stability results (e.g., CTD Module 3.2.P.8.1 or 3.2.P.8.3) must be backed by traceable data during inspections.

Best Practices and Implementation:

Print and archive all critical data at each time point:

For every stability pull, archive the following as part of the batch stability file:

• Raw chromatograms with sample ID, date/time, and analyst signature
• Integration reports and peak identification markers
• Calibration and system suitability records
• Manual calculations or software outputs
• Review and approval signatures

Use controlled binders or validated electronic systems with restricted access for long-term archiving.

Ensure legibility, attribution, and audit trail integrity:

All raw data must be legible, complete, and clearly linked to the corresponding sample and time point. Avoid ambiguous file naming, overlapping records, or undocumented changes. For electronic systems, ensure printouts contain audit trail summaries or include digital annotations that reflect reviewer checks.

Maintain consistent formatting across batches and stability studies to streamline traceability and inspection review.

Train teams and integrate into quality systems:

Train QC analysts and reviewers on the importance of archiving raw data with the final stability file—not separately in equipment folders or digital drives. Include this as a checkpoint in stability SOPs and QA checklists. During internal audits or Annual Product Reviews (APRs), verify that raw data archiving is consistent and complete across all stability programs.

Document this process in your Quality Management System (QMS) and reference it in regulatory filings or audit preparation manuals.

Why comprehensive documentation is critical for stability data:

Stability data alone—such as numerical assay results or degradation percentages—are not sufficient during regulatory inspections. Agencies expect to see complete records supporting how the data was generated, verified, and validated. This includes chromatograms, audit trails, raw data files, and method validation reports.

Maintaining audit-ready documentation is essential to defend the reliability of stability results, confirm GMP compliance, and support product registrations or renewals.

Consequences of incomplete records:

Missing or inaccessible chromatograms, absent audit trails, or unverifiable methods can trigger serious compliance issues. Regulatory authorities may issue 483s, warning letters, or even suspend market authorization if data integrity or traceability cannot be demonstrated.

This tip serves as a reminder that behind every reported value must be a trail of defensible, reviewable, and validated documentation.

Who needs access and how it impacts operations:

QA, QC, Regulatory Affairs, and auditors must be able to retrieve supporting documentation rapidly. A missing audit trail or untraceable chromatogram not only affects product confidence but reflects poorly on the organization’s overall GMP maturity and system controls.

Regulatory and Technical Context:

ICH and GMP expectations:

ICH Q2(R1) requires method validation data, including specificity, accuracy, and robustness, to be archived and traceable. FDA 21 CFR Part 11 and EU Annex 11 emphasize the importance of electronic record traceability, audit trail protection, and documentation control.

During GMP inspections, agencies routinely ask for the following related to stability studies:

• Raw chromatograms with sample identification
• Audit trails showing data creation and modifications
• Validation reports for analytical methods used
• System suitability test records

CTD submission modules and data linkage:

Stability reports in CTD Module 3.2.P.8.3 must be traceable to validated methods documented in Module 3.2.S.4 or 3.2.P.5.4. Any disconnect between submitted data and archived method reports can lead to delays or refusal to file (RTF) responses from regulatory authorities.

Best Practices and Implementation:

Standardize documentation packages for every stability batch:

Create a documentation checklist that includes all relevant records for each stability batch. This should cover:

• Signed protocol and summary report
• Chromatograms (electronic and/or printed)
• Audit trail exports
• System suitability results
• Analytical method validation summary
• Certificate of analysis (CoA)

Store these files in a central, validated Document Management System (DMS) with access control.

Ensure audit trail visibility and protection:

Enable audit trail features in laboratory software (e.g., HPLC, LIMS) and configure systems to prevent deletion or overwriting. Audit trails should capture user actions, time stamps, method changes, and reprocessing events. Periodically review audit trails for anomalies and document findings.

Use electronic signatures to confirm that data review and release steps are performed by authorized personnel.

Link validation files to executed methods:

All analytical methods used in stability testing must have current, approved validation reports on file. Cross-reference each executed method in the study report to its validation number and location. Include a copy or hyperlink in the stability report package for quick retrieval.

Any method updates must be tracked via change control, with a note in the stability summary indicating whether bridging data was needed.